• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铍呈递给CD4+ T细胞是慢性铍病中疾病易感性HLA-DP等位基因的基础。

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

作者信息

Fontenot A P, Torres M, Marshall W H, Newman L S, Kotzin B L

机构信息

Departments of Medicine and Immunology, University of Colorado Health Sciences Center, Denver, CO 80262, USA.

出版信息

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12717-22. doi: 10.1073/pnas.220430797.

DOI:10.1073/pnas.220430797
PMID:11050177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC18830/
Abstract

Chronic beryllium disease results from beryllium exposure in the workplace and is characterized by CD4(+) T cell-mediated inflammation in the lung. Susceptibility to this disease is associated with particular HLA-DP alleles. We isolated beryllium-specific T cell lines from the lungs of affected patients. These CD4(+) T cell lines specifically responded to beryllium in culture in the presence of antigen-presenting cells that expressed class II MHC molecules HLA-DR, -DQ, and -DP. The response to beryllium was nearly completely and selectively blocked by mAb to HLA-DP. Additional studies showed that only certain HLA-DP alleles allowed presentation of beryllium. Overall, the DP alleles that presented beryllium to disease-specific T cell lines match those implicated in disease susceptibility, providing a mechanism for this association. Based on amino acid residues shared by these restricting and susceptibility DP alleles, our results provide insight into the residues of the DP beta-chain required for beryllium presentation.

摘要

慢性铍病是由工作场所接触铍引起的,其特征是肺部CD4(+) T细胞介导的炎症。对这种疾病的易感性与特定的HLA-DP等位基因有关。我们从受影响患者的肺部分离出铍特异性T细胞系。在表达II类MHC分子HLA-DR、-DQ和-DP的抗原呈递细胞存在的情况下,这些CD4(+) T细胞系在培养中对铍有特异性反应。对铍的反应几乎完全且选择性地被抗HLA-DP单克隆抗体阻断。进一步的研究表明,只有某些HLA-DP等位基因能够呈递铍。总体而言,将铍呈递给疾病特异性T细胞系的DP等位基因与那些与疾病易感性相关的等位基因相匹配,为这种关联提供了一种机制。基于这些限制性和易感性DP等位基因共有的氨基酸残基,我们的结果为铍呈递所需的DPβ链残基提供了见解。

相似文献

1
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.铍呈递给CD4+ T细胞是慢性铍病中疾病易感性HLA-DP等位基因的基础。
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12717-22. doi: 10.1073/pnas.220430797.
2
Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.慢性铍病:HLA - DP呈递金属的T细胞识别
Clin Immunol. 2001 Jul;100(1):4-14. doi: 10.1006/clim.2001.5053.
3
Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.铍向CD4+ T细胞的呈递取决于MHC II类β链的单个氨基酸残基。
J Immunol. 2005 Nov 15;175(10):7029-37. doi: 10.4049/jimmunol.175.10.7029.
4
Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.主要组织相容性复合体II类分子在铍致敏和慢性铍病易感性中的作用
J Immunol. 2003 Dec 15;171(12):6910-8. doi: 10.4049/jimmunol.171.12.6910.
5
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.针对铍的HLA - DP等位基因特异性T细胞反应导致了与DP相关的慢性铍病易感性。
J Immunol. 2001 Mar 1;166(5):3549-55. doi: 10.4049/jimmunol.166.5.3549.
6
Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.重组 HLA-DP2 结合铍并使铍特异性致病性 CD4+ T 细胞产生耐受。
J Immunol. 2006 Sep 15;177(6):3874-83. doi: 10.4049/jimmunol.177.6.3874.
7
Linking genetic susceptibility and T cell activation in beryllium-induced disease.将遗传易感性与铍诱导疾病中的 T 细胞激活联系起来。
Proc Am Thorac Soc. 2010 May;7(2):126-9. doi: 10.1513/pats.201002-022RM.
8
T cell recognition in chronic beryllium disease.慢性铍病中的T细胞识别
Clin Immunol. 2006 Nov;121(2):134-43. doi: 10.1016/j.clim.2006.03.012. Epub 2006 May 12.
9
Major histocompatibility locus genetic markers of beryllium sensitization and disease.铍致敏和疾病的主要组织相容性位点遗传标记。
Eur Respir J. 2001 Oct;18(4):677-84. doi: 10.1183/09031936.01.00106201.
10
HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.人类白细胞抗原-DPB1第69位谷氨酸:铍病的一种遗传标志物。
Science. 1993 Oct 8;262(5131):242-4. doi: 10.1126/science.8105536.

引用本文的文献

1
Comparing [H] thymidine LPT and CFSE assay to assess lymphocyte proliferation in beryllium-exposed sarcoidosis patients.比较[H]胸苷掺入试验(LPT)和羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)检测法以评估铍暴露结节病患者的淋巴细胞增殖情况。
Heliyon. 2023 Aug 18;9(9):e19242. doi: 10.1016/j.heliyon.2023.e19242. eCollection 2023 Sep.
2
Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease.组织驻留 Tregs 在铍诱导疾病的小鼠模型中的保护作用。
JCI Insight. 2022 Aug 22;7(16):e156098. doi: 10.1172/jci.insight.156098.
3
A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist.面向基础与转化医学科学家的结节病临床知识入门
J Clin Med. 2021 Jun 28;10(13):2857. doi: 10.3390/jcm10132857.
4
Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.趋化因子新抗原诱导的铍特异性 CD4+T 细胞持续炎症。
J Clin Invest. 2021 May 3;131(9). doi: 10.1172/JCI144864.
5
Environmental Risk Factors for Sarcoidosis.环境因素致结节病。
Front Immunol. 2020 Jun 26;11:1340. doi: 10.3389/fimmu.2020.01340. eCollection 2020.
6
Protective role of B cells in sterile particulate-induced lung injury.B 细胞在无菌性颗粒诱导的肺损伤中的保护作用。
JCI Insight. 2019 May 16;5(12):125494. doi: 10.1172/jci.insight.125494.
7
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.肺动脉高压风险的遗传决定因素:国际全基因组关联研究和荟萃分析。
Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.
8
TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization.TLR9 和 IL-1R1 在铍致敏过程中促进肺部树突状细胞的动员。
J Immunol. 2018 Oct 15;201(8):2232-2243. doi: 10.4049/jimmunol.1800303. Epub 2018 Sep 5.
9
Immunologic Effects of Beryllium Exposure.铍暴露的免疫效应。
Ann Am Thorac Soc. 2018 Apr;15(Suppl 2):S81-S85. doi: 10.1513/AnnalsATS.201707-573MG.
10
Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response.HLA-DPA1等位基因对慢性乙型肝炎预后及治疗反应的影响。
North Clin Istanb. 2017 Jan 25;3(3):168-174. doi: 10.14744/nci.2016.27870. eCollection 2016.

本文引用的文献

1
HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease.人类白细胞抗原-DP分子与钴结合:对与硬质合金病遗传关联的一种可能解释。
Eur J Immunol. 1999 Jul;29(7):2140-7. doi: 10.1002/(SICI)1521-4141(199907)29:07<2140::AID-IMMU2140>3.0.CO;2-Q.
2
Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.不同的Glu69 HLA-DPB1和-DPA1等位基因对慢性铍病的易感性差异。
J Immunol. 1999 Aug 1;163(3):1647-53.
3
Identification of pathogenic T cells in patients with beryllium-induced lung disease.铍诱导性肺病患者中致病性T细胞的鉴定。
J Immunol. 1999 Jul 15;163(2):1019-26.
4
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model.
Eur Respir J. 1998 Dec;12(6):1463-75. doi: 10.1183/09031936.98.12061463.
5
Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis.类风湿关节炎患者滑液中相关CD4 + T细胞克隆的选择性积聚。
J Immunol. 1998 Oct 15;161(8):4428-36.
6
Major histocompatibility complex-directed susceptibility to rheumatoid arthritis.
Adv Immunol. 1998;68:315-32. doi: 10.1016/s0065-2776(08)60563-5.
7
Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes.
Tissue Antigens. 1998 Jan;51(1):51-61. doi: 10.1111/j.1399-0039.1998.tb02946.x.
8
HLA-DP2: self peptide sequences and binding properties.HLA - DP2:自身肽序列及结合特性
J Immunol. 1997 Nov 15;159(10):4935-42.
9
Interaction of genetic and exposure factors in the prevalence of berylliosis.
Am J Ind Med. 1997 Oct;32(4):337-40. doi: 10.1002/(sici)1097-0274(199710)32:4<337::aid-ajim3>3.0.co;2-r.
10
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.HLA - DR1转基因使人对由人II型胶原蛋白引发的胶原诱导性关节炎易感。
J Exp Med. 1997 Mar 17;185(6):1113-22. doi: 10.1084/jem.185.6.1113.